This study presents some of the few available data on contraceptive hormone (medroxyprogesterone acetate) levels among women using depot medroxyprogesterone acetate (DMPA) in Africa. The authors found lower than expected levels among DMPA users with documented injections. This finding highlights the need for more data confirming effectiveness of different DMPA products in different populations, including post-marketing surveillance and pharmacokinetic data and chemical/physical tests for product quality assurance.
Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial
Written By
Nanda K, Callahan R, Taylor D, Wang M, Agot K, Jenkins D, Van Damme L, Dorflinger L, FEM-PrEP study group
